El efecto de la administración de dexametasona materna en la prevención del síndrome de distress respiratorio en el neonato prematuro

Castro Acuña, Virya Elena; Manrique Zuluaga, Antonio José; Celada Quesada, Rolando; Olivares Vassallo, Samuel.
Rev. costarric. cienc. méd ; 19(1/2): 37-48, mar.-jun. 1998. ilus
Artículo en Español | LILACS | ID: lil-257326

Documentos relacionados

  1. Human epididymis protein 4 and fetal lung maturity.
  2. Antenatal Corticosteroids and Preterm Neonatal Morbidity and Mortality among Women with and without Diabetes in Pregnancy.
  3. Response to "Prediction of neonatal respiratory distress in pregnancies complicated by fetal lung masses".
  4. Comment on "Prediction of neonatal respiratory distress in pregnancies complicated by fetal lung masses".
  5. Maduración pulmonar fetal: efectos sobre la morbilidad respiratoria en prematuros tardíos
  6. Bronchopulmonary dysplasia: Pathophysiology and potential anti-inflammatory therapies.
  7. hPSC-derived lung and intestinal organoids as models of human fetal tissue.
  8. Society for Maternal-Fetal Medicine Consult Series #58: Use of antenatal corticosteroids for individuals at risk for late preterm delivery: a response.
  9. Maturation of the cardiac autonomic regulation system, as function of gestational age in a cohort of low risk preterm infants born between 28 and 32 weeks of gestation.
  10. Fetal lung maturity assessment: A historic perspective and Non - invasive assessment using an automatic quantitative ultrasound analysis (a potentially useful clinical tool).